Kovack Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Kovack Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$240K	Buy
2021 Q3	–	Sell
2021 Q2	$232K	Buy